<DOC>
	<DOCNO>NCT00427219</DOCNO>
	<brief_summary>This study compare efficacy safety ozarelix 15 mg. give IM 2 week apart improvement symptom duration improvement 6 month men BPH 50 year age .</brief_summary>
	<brief_title>The Safety Efficacy Ozarelix Treat Men With Lower Urinary Tract Symptoms Due Enlargement Prostate</brief_title>
	<detailed_description>This study compare improvement symptom score , peak flow rate quality life men suffer LUTS secondary BPH follow treatment ozarelix . Ozarelix compare placebo injection give 14 day apart . Patients follow 6 month safety efficacy assess monthly visits.Additionally impact treatment erectile function , , well PSA Testosterone level monitor .</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>All following question must answer `` Yes '' Visit 1 order patient participate study . Is patient least 50 year old ? Does patient clinical sign symptom consistent BPH ? Does patient IPSS Â³13 screening ( prior placebo run ) ? Does patient peak urinary flow rate ( Qmax ) 415 mL/sec establish voided volume least 125 mL ? Is patient willing agree use approve experimental pharmacologic BPH treatment include alpha blocker , 5alpha reductase inhibitor , anticholinergic preparation herbal preparation time study ? All following question must answer `` No '' Visit 1 order patient participate study . Does patient history prostate cancer serum PSA &gt; 10 ng/mL ? Has patient prior prostate bladder surgery , pelvic surgery ( exclude hernia repair ) , pelvic radiation lower urinary tract malignancy ? Does patient prevoid total bladder volume assess ultrasound &gt; 550 mL ? Does patient residual urine volume &gt; 350 mL ultrasound ? Has patient take currently take follow :</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Benign Prostatic Hyperplasia</keyword>
	<keyword>Prostatic Adenoma , Benign</keyword>
	<keyword>Prostatic Hypertrophy , Benign</keyword>
	<keyword>Enlarged Prostate</keyword>
	<keyword>Prostatism</keyword>
	<keyword>Adenoma , Prostatic</keyword>
</DOC>